DVAX Relative Valuation
DVAX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DVAX is overvalued; if below, it's undervalued.
Historical Valuation
Dynavax Technologies Corp (DVAX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.99. The fair price of Dynavax Technologies Corp (DVAX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：10.92
Fair
19.06
PE
1Y
3Y
5Y
Trailing
Forward
23.81
EV/EBITDA
Dynavax Technologies Corp. (DVAX) has a current EV/EBITDA of 23.81. The 5-year average EV/EBITDA is 64.32. The thresholds are as follows: Strongly Undervalued below -330.45, Undervalued between -330.45 and -133.07, Fairly Valued between 261.70 and -133.07, Overvalued between 261.70 and 459.09, and Strongly Overvalued above 459.09. The current Forward EV/EBITDA of 23.81 falls within the Historic Trend Line -Fairly Valued range.
22.60
EV/EBIT
Dynavax Technologies Corp. (DVAX) has a current EV/EBIT of 22.60. The 5-year average EV/EBIT is 46.58. The thresholds are as follows: Strongly Undervalued below -131.62, Undervalued between -131.62 and -42.52, Fairly Valued between 135.69 and -42.52, Overvalued between 135.69 and 224.79, and Strongly Overvalued above 224.79. The current Forward EV/EBIT of 22.60 falls within the Historic Trend Line -Fairly Valued range.
3.35
PS
Dynavax Technologies Corp. (DVAX) has a current PS of 3.35. The 5-year average PS is 4.25. The thresholds are as follows: Strongly Undervalued below 0.86, Undervalued between 0.86 and 2.56, Fairly Valued between 5.95 and 2.56, Overvalued between 5.95 and 7.64, and Strongly Overvalued above 7.64. The current Forward PS of 3.35 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Dynavax Technologies Corp. (DVAX) has a current P/OCF of 0.00. The 5-year average P/OCF is 32.63. The thresholds are as follows: Strongly Undervalued below -105.75, Undervalued between -105.75 and -36.56, Fairly Valued between 101.82 and -36.56, Overvalued between 101.82 and 171.02, and Strongly Overvalued above 171.02. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
18.08
P/FCF
Dynavax Technologies Corp. (DVAX) has a current P/FCF of 18.08. The 5-year average P/FCF is 50.62. The thresholds are as follows: Strongly Undervalued below -329.93, Undervalued between -329.93 and -139.65, Fairly Valued between 240.90 and -139.65, Overvalued between 240.90 and 431.18, and Strongly Overvalued above 431.18. The current Forward P/FCF of 18.08 falls within the Historic Trend Line -Fairly Valued range.
Dynavax Technologies Corp (DVAX) has a current Price-to-Book (P/B) ratio of 2.41. Compared to its 3-year average P/B ratio of 2.57 , the current P/B ratio is approximately -6.20% higher. Relative to its 5-year average P/B ratio of 6.22, the current P/B ratio is about -61.24% higher. Dynavax Technologies Corp (DVAX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 5.10%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 5.74% , the current FCF yield is about -100.00% lower.
2.41
P/B
Median3y
2.57
Median5y
6.22
6.25
FCF Yield
Median3y
5.10
Median5y
5.74
Competitors Valuation Multiple
The average P/S ratio for DVAX's competitors is , providing a benchmark for relative valuation. Dynavax Technologies Corp Corp (DVAX) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 17.67%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of DVAX decreased by 14.17% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 21.82 to 28.38.
The secondary factor is the Revenue Growth, contributed 17.67%to the performance.
Overall, the performance of DVAX in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Dynavax Technologies Corp (DVAX) currently overvalued or undervalued?
What is Dynavax Technologies Corp (DVAX) fair value?
How does DVAX's valuation metrics compare to the industry average?
What is the current P/B ratio for Dynavax Technologies Corp (DVAX) as of Dec 05 2025?
What is the current FCF Yield for Dynavax Technologies Corp (DVAX) as of Dec 05 2025?
What is the current Forward P/E ratio for Dynavax Technologies Corp (DVAX) as of Dec 05 2025?